Published date: 24 May 2024

Last edited date: 26 June 2024

This notice was replaced on 17 December 2024

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 17 December 2024)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Laboratory building construction work - 45214610

Location of contract

GU24 0NF

Value of contract

£6,500,000

Procurement reference

CVIM/D&B/2024

Published date

24 May 2024

Closing date

5 July 2024

Closing time

12pm

Contract start date

28 August 2024

Contract end date

9 January 2026

Contract type

Works

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

A joint initiative between the Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation (UKRI), the Foreign, Commonwealth and Development Office (FCDO) and the Bill & Melinda Gates Foundation will see the creation of a new centre at The Pirbright Institute designed to accelerate the development of animal vaccines to combat emerging and urgent infectious diseases.

The consequences of livestock disease can be catastrophic. As well as posing a very real risk to global food security and international trade, livestock disease also presents a significant threat to global human health due to its pandemic potential.

While the UK remains a world-leader in the early-stage development of vaccines for both human and veterinary medicine, globally we need to strengthen our collective capacity to translate scientific discoveries into solutions for the most challenging veterinary infectious diseases.

The new Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) will bridge the gaps between research and expertise in process development and manufacturing while strengthening the UK's own emergency response capacity and capability. It will bring about tangible health and economic benefits by focusing on diseases prevalent in low- and middle-income countries.

Procurement Route - Design and Build

Tender Strategy - 'Open Procedure' Single Stage Tender

Design Stage - Stage 3

Form of Contract - NEC4 Option A: Fixed Price with Activity Schedule

The successful Contractor will be responsible for designing and building a c.590m2 new-build facility for The Pirbright Institute, c.461m2 of functional space on the ground floor and c.129m2 of plant space on the first floor.

1) General building outline: New build facility, 590m2, two story above ground, with all functions on ground floor, and plant room on the first floor, comprising of 1 nr GMP cleanroom (ISO007), 1 nr cold-room (CNC), 1 nr freezer room, RM Storage and receipt areas, 1 nr QC Micro lab (CNC), 1 nr QC lab (CNC), a write up area/office and all supporting areas including a plant room and associated external works.

2) The building will be constructed within the existing Pirbright site.

3) Achieve Part L - 2, target for Net Zero Carbon (NZC).

The design of the facility will include biocontainment (ACDP CL2/SAPO2/GMO2), BREEAM: Very Good, cleanrooms (up to ISO7), good manufacturing practice (GMP), net-zero carbon and equity, diversity and inclusion (EDI). The project team have developed the RIBA stage 3 design in accordance with the end-user requirements.

The project team that developed the RIBA Stage 3 design in conjunction with the end-user requirements were as follows.

• Project Manager - Currie and Brown
• Cost Manager - Turner and Townsend
• Multi-Disciplinary Design Consultant / CMT - Scitech

More information

Attachments

  • Addendum to Appendix 3 - Contract documents.zip
  • Contract draft
  • Please note that Addendum to Appendix 3 - Contract documents that includes NEC4 2017 - Sample Form of Agreement R3 replaces Appendix 3 - Contract documents that includes NEC4 2017 - Sample Form of Agreement(332790303.5) (TTa)

    Please ensure that you review NEC4 2017 - Sample Form of Agreement R3.

    The main changes are listed below for convenience:

    - Addressing the fact that the contractor is to be responsible for the entire design, and risk.
    - Non selection of option X15
    - No sectional completion
    - Defining 'beneficiaries' with regards to collateral warranties
    - Amending references to 'appendices' in lieu of annex's (As per our ITT folder structure)
  • Addendum to Appendix 3 - Contract documents R4.zip
  • Contract draft
  • Please note that Addendum to Appendix 3 - Contract documents that includes NEC4 2017 - Sample Form of Agreement R4 replaces Appendix 3 - Contract documents that includes NEC4 2017 - Sample Form of Agreement R3.

    Please ensure that you review NEC4 2017 - Sample Form of Agreement R4.

Additional text

Please note that Appendix 1 - Confidentiality Agreement must be completed, signed, and emailed to procurement@pirbrightinnovations.co.uk asap. Then and only then will access to the full ITT package (Appendices 4 & 5) be granted to the requester.

About the buyer

Address

Ash Road
Pirbright
WOKING
GU24 0NF
England

Email

procurement@pirbrightinnovations.co.uk